Modulation of camptothecin analogs in the treatment of cancer: a review.
about
Inorganic nanolayers: structure, preparation, and biomedical applicationsNonlinear partial differential equations and applications: The mechanism of topoisomerase I poisoning by a camptothecin analogDesign and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I.Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38A sandwiched microarray platform for benchtop cell-based high throughput screening.Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitorsThe role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical DevelopmentModulation of oral drug bioavailability: from preclinical mechanism to therapeutic application.A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targetingA phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin.Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.Anticancer carrier-linked prodrugs in clinical trials.Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer.Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivatives.The use of endophytes to obtain bioactive compounds and their application in biotransformation process.Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.Perspectives in camptothecin development
P2860
Q26781178-19E6E7CD-D6B9-49DB-9386-E385F140DCAAQ27639935-A8686274-C6B3-4AFA-A054-31B30F5FB33BQ31031515-26BAB873-907F-4C5E-AA99-971813645F50Q33183914-85551AF5-358A-41F6-A8BB-0240E7E42B1BQ33724982-A18DCFFB-CE58-47DD-9B3C-FB34B611E769Q33725863-BB80C540-A8E9-4553-B0FE-D36B3223EB04Q33925422-00AB7726-B1E2-4D57-926E-0DAF9E70ED25Q35237593-E65CAC37-F31C-4078-95BC-6D49B9BC16C0Q36271954-4AC7493B-0CAC-4489-8D6E-FFB31E2E8B18Q36327549-DCF22475-56C6-4D0F-A14F-9645F1D7F046Q36624086-4336C0E1-19B5-430E-8486-6766B2E6545FQ36642304-F4962265-1213-4954-9A28-1248318A15B7Q36861603-2234D27F-F998-44CE-9073-E44D0A7DBD0EQ37046332-E2670C5A-A823-4DAB-AD1A-ABD803ED1283Q37394856-2B2AC63C-9750-48ED-A335-E1789351470FQ37708736-121A677C-C2EF-42EC-9758-A9DD8F8F1B46Q38891812-4F9534F6-0B7C-461F-84E5-CC626A0AFB3EQ39777927-B17C6ADD-EFA6-4E1C-8845-196D4AD19A8CQ42620744-4AD44766-04BC-4E59-BCEB-E54EAECDB494Q47727028-4FAA7F88-2E41-4ECB-9526-F24D87DFAF8DQ59081838-4264008C-DD74-4F51-A4DF-35F9A4BAC0C2
P2860
Modulation of camptothecin analogs in the treatment of cancer: a review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modulation of camptothecin analogs in the treatment of cancer: a review.
@ast
Modulation of camptothecin analogs in the treatment of cancer: a review.
@en
type
label
Modulation of camptothecin analogs in the treatment of cancer: a review.
@ast
Modulation of camptothecin analogs in the treatment of cancer: a review.
@en
prefLabel
Modulation of camptothecin analogs in the treatment of cancer: a review.
@ast
Modulation of camptothecin analogs in the treatment of cancer: a review.
@en
P2093
P1433
P1476
Modulation of camptothecin analogs in the treatment of cancer: a review.
@en
P2093
Soepenberg O
Sparreboom A
P304
P356
10.1097/00001813-200102000-00002
P577
2001-02-01T00:00:00Z